Thomas, G. A. O., et al, Eur. J. Gastroenterol, 8, 769-776 (1996). |
Lichtiger S., et al, N. Engl. J. Med. 330, No. 26, 1841-1845 (Jun. 30, 1994). |
Sandborn, W. J., et al, Gastroenterology, 108, 1429-1435 (1994). |
Thomas, G. A. O., et al, N. Engl. J. Med., 332, No. 15, 988-992 (Apr. 19, 1995). |
Lichtiger, S., et al, Gastroenterology, vol. 104, No. 4, Part 2, p. A732 AGA Abstracts (Apr. 1993). |
Zins, B. J., et al, Gastroenterology, vol. 110, No. 4, p. A1054 (Apr. 1996). |
Cecil Textbook of Medicine, 19th edition, edited by Wyngaarden, J.B. et al, W.B. Saunders Co., pp. 699-708, Oct. 1992. |
Handbook of Pharmaceutical Excipients, 2nd edition, 363. |
Danish Budesinode Study Group, Scand J. Gastroent., 1991, 26, pp. 1225-1230. |
Winter, T.A. et al, Scand. J. Gastroent., 1993, 28(8), pp. 701-704, abstract only. |
"Noncompartmental Analysis Based on Statistical Momemt Theory", Pharmacokinetics, 2nd ed., M. Gibaldi (ed), Marcel Dekker Inc., New York, pp. 409-417, (1982). |
"Rectal Topical Corticosteroid Preparations", Drug and Therapeutics Bulletin, 29, Publ. Consumer' Association, London, pp. 66-68, (1991). |
N. L. Benowitz, et al., "Stable Isotope Studies of Nicotine Kinetics and Bioavailability", Clin. Pharmacol. Ther., 49, 270-277, (1991). |
M. H. Brock, et al., "Use of In Vitro and In Vivo Data in the Design, Development, and Quality Control of Sustained-Release Decongestant Dosage Forms", Pharmacotherapy, 14, 430-437, (1994). |
P. Dominiak, et al., "Effects of nicotine and its major metabolites on blood pressure in anesthetized rate", Klin. Wochenschr., 63, 90-92 (1985),. |
M. J. Durrani, et al., "Studies on Drug Release Kinetics from Carbopol 934P Tablets", Pharmaceutical Res. (Suppl.), 8, S-135, (1991). |
S. Edsbacker, et al., "Pharmacokinetics and Gastrointestinal Transit of Budesonide Controlled Ileal Release (CIR) Capsules", Gastroenterology (Supp), 104, A695, (Apr. 1993). |
D. F. Glenn, et al., "Synthesis and Mass Spectrometry of Some Structurally Related Nicotinoids", J. Org. Chem., 43, 2860-70, (1978). |
G. R. Greenberg, et al., "Oral Budesonide for Active Crohn's Disease", NEJM, 331, 836-41, (1994). |
D. A. Hutton, et al., "Mucolysis of the Colonic Mucus Barrier By Faecal Proteinases: Inhibition by Interacting Polyacrylate", Clin. Sci. 78, 265-271, (1990). |
L. G. Miller, et al., "Reversible Alterations in Immunoregulatory T Cells in Smoking", Chest, 82, No. 5, 526-529, (1982). |
R. D. Pullan, et al., "Comparison of Bismuth Citrate and 5-aminosalicylic Acid Enemas in Distal Ulcerative Colitis: A Controlled Trial", Gut, 34, 676-679, (1993). |
R. D. Pullan, et al., "Transdermal Nicotine for Active Ulcerative Colitis", NEJM, 330, No. 12, 811-815, (Mar. 24, 1994). |
C. J. Roberts, et al., "Non-smoking: A Feature of Ulcerative Colitis", Br. Med. J., 285, 440, (1982). |
W. J. Sandborn, et al., "The Pharmokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration", J. Clin. Pharmacol., 31, 76-80, (1991). |
K. W. Schroeder, et al., "Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis", NEJM, 317, 1625-29, (1987). |
E. D. Srivastava, et al., "Transdermal Nicotine in Active Ulcerative Colitis", Eur. J. Gastro. & Hepat., 3, 815-818, (1991). |
L. R. Sutherland, "Topical Treatment of Ulcerative Colitis", Medical Clinics of North America, 74, 119-131, (1990). |
G. A. O. Thomas, "Nicotine Therapy for Ulcerative Colitis", Dissertation for the degree of Doctor of Medicine, London University, (Jul. 1995). |